Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Erectile Dysfunction 8Prostatic Neoplasms 7Rectal Neoplasms 2Neoplasms 2Fatigue 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vascular Malformations 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Solid Tumor 1Sexuality 1Sexual Dysfunction, Physiological 1Sarcoma 1Pre-Eclampsia 1Postoperative Complications 1Penile Neoplasms 1Pancreatic Neoplasms 1Neurologic Manifestations 1Mental Fatigue 1Lymphoma, Follicular 1Lymphatic Abnormalities 1Lymphangioma 1Infertility 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Erectile Dysfunction Following Radical Prostatectomy 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × Sildenafil Citrate × Clear all
NCT01817751 2024-07-17

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Virginia Commonwealth University

Phase 2 Completed
47 enrolled 13 charts
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡